24.04.2013
- Amgen on Tuesday reported first-quarter sales that fell short of Wall Street expectations for most of its biggest-selling medicines, and its shares fell more than 6%. Revenue for...
25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
08.03.2011
- Actelion, Europe's largest biotech company, has the backing of Rudolf Maag, one its largest shareholders, a spokeswoman for Maag said on Monday. The company is coming under...
08.01.2013
- Sartorius Stedim Biotech, a pharmaceutical and biotech supplier, today announced a substantial expansion of its product rray in the cell culture range. The company signed a...